September 29, 2025 This may be one of the most important blogs I ever write
Do not change the drip rate or move the IV bag as this may affect your treatment/therapy outcome
Aug 18: Regeneron Pharmaceuticals Veopoz (pozelimab) secured FDA approval as the first and only treatment indicated specifically for CHAPLE disease, also known as CD55-deficient protein-losing enteropathy, an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study
No link with suicide thoughts or behavior Importantly, the results showed that GLP-1RAs were not associated with a worsening of mental state, suicidal behaviour, new mental illness diagnoses, or increased psychiatric admissions
L-Carnitine also facilitates the metabolism of carbohydrates and enhances the rate of oxidative phosphorylation, the final stage of ATP (i.e., energy) production